Cosmos Technology International Berhad (KLSE:COSMOS)

CTI BioPharma Ratios and Metrics

Market cap in millions MYR. Fiscal year is May - April.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 31, 2025	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021
Market Capitalization	76	77	124	121	-	-
Market Cap Growth	-38.14%	-38.14%	3.19%	-	-	-
Enterprise Value	52	56	122	107	-	-
Last Close Price	0.29	0.30	0.48	0.46	-	-
PE Ratio	32.52	-	54.21	32.85	-	-
Forward PE	-	16.55	16.55	16.55	-	-
PS Ratio	3.77	3.84	3.47	2.07	-	-
PB Ratio	1.76	1.79	2.35	2.38	-	-
P/TBV Ratio	1.76	1.79	2.35	2.38	-	-
P/FCF Ratio	53.86	54.77	-	-	-	-
P/OCF Ratio	32.62	33.17	44.29	183.22	-	-
PEG Ratio	-	1.00	1.00	1.00	-	-
EV/Sales Ratio	2.61	2.80	3.42	1.83	-	-
EV/EBITDA Ratio	10.94	11.71	23.02	15.86	-	-
EV/EBIT Ratio	15.48	16.58	35.10	19.47	-	-
EV/FCF Ratio	37.28	39.94	-	-	-	-
Debt / Equity Ratio	0.05	0.05	0.17	0.21	0.31	0.25
Debt / EBITDA Ratio	0.40	0.40	1.68	1.53	0.86	0.60
Debt / FCF Ratio	1.37	1.37	-	-	2.71	-
Asset Turnover	0.34	0.34	0.51	0.97	1.18	0.94
Inventory Turnover	1.34	1.34	2.25	4.28	3.36	2.06
Quick Ratio	4.16	4.16	2.69	2.18	1.72	1.44
Current Ratio	5.22	5.22	4.18	2.84	2.45	2.28
Return on Equity (ROE)	4.85%	4.85%	4.42%	9.50%	24.46%	31.10%
Return on Assets (ROA)	3.60%	3.60%	3.08%	5.71%	12.54%	13.38%
Return on Capital (ROIC)	3.96%	3.96%	3.53%	7.13%	17.27%	21.44%
Return on Capital Employed (ROCE)	7.80%	7.80%	6.10%	10.00%	28.90%	33.70%
Earnings Yield	-11.67%	-11.47%	1.85%	3.04%	-	-
FCF Yield	1.86%	1.83%	-1.64%	-10.94%	-	-
Dividend Yield	1.69%	1.67%	-	1.08%	-	-
Payout Ratio	-	-	-	34.96%	-	-
Buyback Yield / Dilution	-	0.00%	-12.13%	-18.90%	25.00%	-
Total Shareholder Return	1.75%	1.67%	-12.13%	-17.82%	25.00%	-

Updated Dec 18, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.